US Markets

NZ's Abano Healthcare enters $80 mln buyout deal with consortium

Abano Healthcare Group Ltd said on Monday it entered a revised buyout deal with a consortium, after the initial offer was dropped due to deterioration in the medical services provider's business because of the coronavirus pandemic.

Aug 31 (Reuters) - Abano Healthcare Group Ltd ABA.NZ said on Monday it entered a revised buyout deal with a consortium, after the initial offer was dropped due to deterioration in the medical services provider's business because of the coronavirus pandemic.

The revised all-cash offer values Abano's equity at NZ$117 million ($78.78 million), it said in a statement to the stock exchange.

The consortium, owned by private equity firm BGH Capital and the Ontario Teachers' Pension Plan Board, will pay NZ$4.45 per share, lower than its March offer of NZ$5.70.

The new offer represents a premium of over 70% to Abano's last close of NZ$2.61, and removed the suitors' right to terminate the deal in the event of any material adverse changes in Abano's business, unlike the earlier one.

The earlier offer was terminated under the material adverse changes condition, after a number of Abano's practices were shut due to restrictions to tackle the coronavirus outbreak.

($1 = 1.4852 New Zealand dollars)

(Reporting by Rashmi Ashok in Bengaluru; Editing by Peter Cooney)

((Rashmi.Ashok@thomsonreuters.com; +918061822604;))

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Latest Markets Videos

Reuters

Reuters, the news and media division of Thomson Reuters, is the world’s largest international multimedia news provider reaching more than one billion people every day. Reuters provides trusted business, financial, national, and international news to professionals via Thomson Reuters desktops, the world's media organizations, and directly to consumers at Reuters.com and via Reuters TV.

Learn More